These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6832192)

  • 1. Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.
    Nieto MJ; Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Eur J Clin Pharmacol; 1983; 24(1):109-12. PubMed ID: 6832192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.
    Ohkawa M; Takamae K; Shimamura M; Kuroda K; Awazu S
    Chemotherapy; 1981; 27(3):149-54. PubMed ID: 7226971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pharmacokinetics and bioavailability of cefroxadine (CGP 9000) and renal function.
    Bergan T; Brodwall EK; Larsen EW
    Chemotherapy; 1983; 29(3):163-73. PubMed ID: 6872614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.
    Bergan T
    Chemotherapy; 1980; 26(4):225-30. PubMed ID: 7389422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
    Srinivasan S; Neu HC
    Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefroxadin (CGP 9000) in man.
    Gerardin A; Lecaillon JB; Schoeller JP; Humbert G; Guibert J
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):15-26. PubMed ID: 7069577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of cephradine to patients in renal failure.
    Solomon AE; Briggs JD
    Br J Clin Pharmacol; 1975 Oct; 2(5):443-8. PubMed ID: 786357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.
    Dominguez-Gil A; Lanao JM; Tabernero JM; Rodriguez Commes JL; de Castro S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):49-52. PubMed ID: 499300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the transfer of cefroxadine to human tears].
    Hara J; Tanaka Y; Harino S; Deguchi K
    Jpn J Antibiot; 1985 Feb; 38(2):230-4. PubMed ID: 4009946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of Dibekacin in patients undergoing haemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Rubio F; Martin A
    Eur J Clin Pharmacol; 1980 Oct; 18(4):347-50. PubMed ID: 7439256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Bondia Román A
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):366-70. PubMed ID: 489205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
    Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
    Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].
    Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Eandi M
    Minerva Med; 1981 Apr; 72(13):813-8. PubMed ID: 7219791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceforanide kinetics in renal insufficiency.
    Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.